Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion

Nature

Volumn 403, Issue 6768, 2000, Pages 430-434

  Delfs, J M ^a   Zhu, Y ^a   Druhan, J P ^a   Aston Jones, G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERSION; BRAIN REGION; CONDITIONING; CONTROLLED STUDY; FOREBRAIN; MALE; NERVE PROJECTION; NONHUMAN; NORADRENERGIC SYSTEM; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; AMYGDALA; ANIMALS; BETAXOLOL; CLONIDINE; MALE; NARCOTICS; NEURONS, AFFERENT; NOREPINEPHRINE; PROPANOLAMINES; PROPRANOLOL; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; TERMINALIS;

EID: 0034719355     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35000212     Document Type: Article

References (30)

1. Bechara, A., Nader, K. & van der Kooy, D. A two-separate-motivational-systems hypothesis of opioid addiction. Pharmacol. Biochem. Behav. 59, 1-17 (1998).
2. O'Brien, C. P., Childress, A. R., McLellan, A., Ehrman, R. & Ternes, J. Types of conditioning found in drug-dependent humans. NIDA Res. Monogr. 84, 44-61 (1988).
3. Maldonado, R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci. Biobehav. Rev. 21, 91-104 (1997).
4. Aston-Jones, G., Shiekhattar, R. Rajkowski, J., Kubiak, P. & Akaoka, H. in The Neurobiology of Opiates (ed. Hammer, R.) 175-202 (CRC Press, Boca Raton, Florida, 1993).
5. Alheid, G. F., de Olmos, J. S. & Beltramino, C. A. in The Rat Nervous System 2nd edn (ed. Paxinos, G.) 495-578 (Academic, San Diego, 1995).
6. Brownstein, M. J. & Palkovits, M. in Handbook of Chemical Neuroanatomy, Vol. 2. Classical Transmitters in the CNS, Part I (eds Bjorklund, A. & Hokfelt, T.) 23-54 (Elsevier, Amsterdam, 1984).
7. Terenzi, M. G. & Ingram, C. D. A combined immunocytochemical and retrograde tracing study of noradrenergic connections between the caudal medulla and the bed nuclei of the stria terminalis. Brain Res. 672, 289-297 (1995).
8. Akaoka, H., Zhu, Y., Shipley, M. T. & Aston-Jones, G. Expression of fos protein in central catecholamine neurons during opiate withdrawal. Soc. Neurosci. Abstr. 18, 374 (1992).
9. Stornetta, R. L., Norton, F. E. & Guyenet, P. G. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res. 624, 19-28 (1993).
10. Harris, G. & Aston-Jones, G. Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal. Neuropsychopharmacology 9, 303-311 (1993).
11. Fritschy, J. M., Geffard, M. & Grzanna, R. The response of noradrenergic axons to systematically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-β-hydroxylase. J. Chem. Neuroanat. 3, 309-321 (1990).
12. Christie, M. J., Williams, J. T., Osbourne, P. B. & Bellchambers, C. E. Where is the locus of opioid withdrawal? Trends Pharmacol. Sci. 18, 134-140 (1997).
13. Caille, S. et al. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J. Pharmacol. Exp. Ther. 290, 881-892 (1999).
14. Nader, K. & van der Kooy, D. Clonidine antagonizes the aversive effects of opiate withdrawal and the rewarding effects of morphine only in opiate withdrawn rats. Behav. Neurosci. 110, 389-400 (1996).
15. Gold, M. S., Redmond, D. E. & Kleber, H. D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet (ii), 599-602 (1978).
16. Roehrich, H. & Gold, M. S. Propranolol as adjunct to clonidine in opiate detoxification. Am. J. Psychiat. 144, 1099-1100 (1987).
17. Grosz, H. J. Narcotic withdrawal symptoms in heroin users treated with propranolol. Lancet (ii), 564-566 (1972).
18. Chieng, B. & Christie, M. J. Lesions to terminals of noradrenergic locus coeruleus neurones do not inhibit opiate withdrawal behaviour in rats. Neurosci. Lett. 186, 37-40 (1995).
19. Britton, K. T., Svensson, T., Schwartz, J., Bloom, F. E. & Koob, G. F. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine. Life Sci. 34, 133-139 (1984).
20. Blessing, W. W. The Lower Brainstem and Bodily Homeostasis (Oxford Univ. Press, New York, 1997).
21. Stinus, L., Le Moal, M. & Koob, G. F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37, 767-773 (1990).
22. Schulteis, G., Markou, A., Gold, L. H., Stinus, L. & Koob, G. F. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J. Pharmacol. Exp. Ther. 271, 1391-1398 (1994).
23. Higgins, G. A. & Sellers, E. M. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharm. Biochem. Behav. 48, 1-8 (1994).
24. Pothos, E., Rada, P., Mark, G. P. & Hoebel, B. G. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 566, 348-350 (1991).
25. McKittrick, C. R., Delfs, J. M., Aston-Jones, G. & Abercrombie, E. D. Differential spontaneous and withdrawal-induced efflux of catecholamines in nucleus accumbens shell of morphine-treated rats. Soc. Neurosci. Abstr. 25, 948 (1999).
26. Harris, G. & Aston-Jones, G. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371, 155-157 (1994).
27. Drolet, G., Van Bockstaele, E. J. & Aston-Jones, G. Robust enkephalin innervation of the locus coeruleus from the rostral medulla. J. Neurosci. 12, 3162-3174 (1992).
28. Chen, S. & Aston-Jones, G. Extensive projections from the midbrain periaqueductal gray to the caudal ventrolateral medulla: A retrograde and anterograde tracing study in the rat. Neurosci. 71, 443-459 (1996).
29. Everitt, B. J., Robbins, T. W., Gaskin, M. & Fray, P. J. The effects of lesions to ascending noradrenergic neurons on discrimination learning and performance in the rat. Neuroscience 10, 397-410 (1983).
30. Tejani-Butt, S. M. 3H-nisoxetine: a radioligand for quantification of norepinephrine uptake sites by autoradiography or by homogenate binding. J. Pharm. Exp. Ther. 260, 427-436 (1992).